(Q43971013)

28 November 2017

1 reference

title

Genes and coronary heart disease (English)

1 reference

28 November 2017

Francisco Navarro-López

series ordinal

1

1 reference

PubMed ID

11975906

28 November 2017

language of work or name

Spanish

0 references

publication date

1 April 2002

1 reference

Revista Española de Cardiología

28 November 2017

1 reference

28 November 2017

55

1 reference

28 November 2017

4

1 reference

28 November 2017

413-431

1 reference

The increased risk of death from ischaemic heart disease in first degree relatives of 121 men and 96 women with ischaemic heart disease.

28 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976620-7

7 January 2021

Genetic susceptibility to death from coronary heart disease in a study of twins

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976620-7

7 January 2021

Genética y medicina molecular en cardiología

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976620-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976620-7

1 reference

7 January 2021

A receptor-mediated pathway for cholesterol homeostasis

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976620-7

7 January 2021

Importance of HDL cholesterol levels and the total/ HDL cholesterol ratio as a risk factor for coronary heart disease in molecularly defined heterozygous familial hypercholesterolaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976620-7

7 January 2021

Familial hypercholesterolaemia in Finland: common, rare and mild mutations of the LDL receptor and their clinical consequences. Finnish FH-group

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976620-7

7 January 2021

Pvu II intron 15 polymorphism at the LDL receptor gene is associated with differences in serum lipid concentrations in subjects with low and high risk for coronary artery disease from Brazil

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976620-7

7 January 2021

Association of the insertion/deletion gene polymorphism of the apolipoprotein B signal peptide with myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976620-7

7 January 2021

Apolipoprotein polymorphisms fail to define risk of coronary artery disease. Results of a prospective, angiographically controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976620-7

7 January 2021

Apolipoprotein E genotype: epsilon32 women are protected while epsilon43 and epsilon44 men are susceptible to ischemic heart disease: the Copenhagen City Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976620-7

7 January 2021

Apolipoprotein E Alleles and Risk of Coronary Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976620-7

7 January 2021

The apolipoprotein epsilon4 allele determines prognosis and the effect on prognosis of simvastatin in survivors of myocardial infarction : a substudy of the Scandinavian simvastatin survival study

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976620-7

7 January 2021

The response to lovastatin treatment in patients with heterozygous familial hypercholesterolemia is modulated by apolipoprotein E polymorphism

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976620-7

7 January 2021

Apolipoprotein E and B polymorphisms--longevity factors assessed in nonagenarians

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976620-7

7 January 2021

Polymorphisms of the genes encoding apoproteins A-I, B, C-III, and E and LDL receptor, and cholesterol and LDL metabolism during increased cholesterol intake. Common alleles of the apoprotein E gene show the greatest regulatory impact

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976620-7

7 January 2021

Lipoprotein(a) and atherogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976620-7

7 January 2021

Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976620-7

7 January 2021

Lipoprotein (a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976620-7

7 January 2021

High density lipoproteins and arteriosclerosis. Role of cholesterol efflux and reverse cholesterol transport

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976620-7

7 January 2021

Lipoprotein lipase mutations, plasma lipids and lipoproteins, and risk of ischemic heart disease. A meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976620-7

7 January 2021

Triglyceride as a risk factor for coronary artery disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976620-7

7 January 2021

Lipoprotein lipase variants D9N and N291S are associated with increased plasma triglyceride and lower high-density lipoprotein cholesterol concentrations: studies in the fasting and postprandial states: the European Atherosclerosis Research Studies.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976620-7

7 January 2021

Molecular genetic study of Finns with hypoalphalipoproteinemia and hyperalphalipoproteinemia: a novel Gly230 Arg mutation (LCAT[Fin]) of lecithin:cholesterol acyltransferase (LCAT) accounts for 5% of cases with very low serum HDL cholesterol levels

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976620-7

7 January 2021

The Role of a Common Variant of the Cholesteryl Ester Transfer Protein Gene in the Progression of Coronary Atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976620-7

7 January 2021

Alcohol intake modulates the effect of a polymorphism of the cholesteryl ester transfer protein gene on plasma high density lipoprotein and the risk of myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976620-7

7 January 2021

Paraoxonase genes and disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976620-7

7 January 2021

Effect of the human serum paraoxonase 55 and 192 genetic polymorphisms on the protection by high density lipoprotein against low density lipoprotein oxidative modification

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976620-7

7 January 2021

The Gln/Arg polymorphism of human paraoxonase (PON 192) is not related to myocardial infarction in the ECTIM Study

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976620-7

7 January 2021

Serum paraoxonase (PON1) 55 and 192 polymorphism and paraoxonase activity and concentration in non-insulin dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976620-7

7 January 2021

Risk of myocardial infarction associated with Gln/Arg 192 polymorphism in the human paraoxonase gene and diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976620-7

7 January 2021

Tobacco smoking modifies association between Gln-Arg192 polymorphism of human paraoxonase gene and risk of myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976620-7

7 January 2021

Novel polymorphisms in promoter region of atp binding cassette transporter gene and plasma lipids, severity, progression, and regression of coronary atherosclerosis and response to therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976620-7

7 January 2021

Variation at the hepatic lipase and apolipoprotein AI/CIII/AIV loci is a major cause of genetically determined variation in plasma HDL cholesterol levels

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976620-7

7 January 2021

Association of angiotensinogen gene T235 variant with increased risk of coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976620-7

7 January 2021

Genetic polymorphisms of the renin-angiotensin system and angiographic extent and severity of coronary artery disease: the CORGENE study

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976620-7

7 January 2021

Angiotensinogen mutations and risk for ischemic heart disease, myocardial infarction, and ischemic cerebrovascular disease. Six case-control studies from the Copenhagen City Heart Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976620-7

7 January 2021

Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976620-7

7 January 2021

A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976620-7

7 January 2021

A meta-analysis of the association of the deletion allele of the angiotensin-converting enzyme gene with myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976620-7

7 January 2021

ACE gene polymorphism in cardiovascular disease: meta-analyses of small and large studies in whites

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976620-7

7 January 2021

Large-scale test of hypothesised associations between the angiotensin-converting-enzyme insertion/deletion polymorphism and myocardial infarction in about 5000 cases and 6000 controls. International Studies of Infarct Survival (ISIS) Collaborators

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976620-7

7 January 2021

Searching for a better assessment of the individual coronary risk profile. The role of angiotensin-converting enzyme, angiotensin II type 1 receptor and angiotensinogen gene polymorphisms

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976620-7

7 January 2021

Deletion-type allele of the angiotensin-converting enzyme gene is associated with progressive ventricular dilation after anterior myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976620-7

7 January 2021

The D-allele of the ACE polymorphism is related to increased QT dispersion in 609 patients after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976620-7

7 January 2021

Plasma Activity and Insertion/Deletion Polymorphism of Angiotensin I–Converting Enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976620-7

7 January 2021

The angiotensin-converting enzyme gene and the angiotensin II type I receptor gene as candidate genes for microalbuminuria. A study in nondiabetic and non-insulin-dependent diabetic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976620-7

7 January 2021

Insertion/deletion polymorphism of the angiotensin-converting enzyme gene is strongly associated with coronary heart disease in non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976620-7

7 January 2021

Evidence for association and genetic linkage of the angiotensin-converting enzyme locus with hypertension and blood pressure in men but not women in the Framingham Heart Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976620-7

7 January 2021

Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976620-7

7 January 2021

Angiotensin II type 1 receptor A1166C gene polymorphism. Absence of an association with the risk of coronary artery disease and myocardial infarction and of a synergistic effect with angiotensin-converting enzyme gene polymorphism on the risk of the

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976620-7

7 January 2021

The genotype interactions of methylenetetrahydrofolate reductase and renin-angiotensin system genes are associated with myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976620-7

7 January 2021

Chymase gene locus is not associated with myocardial infarction and is not linked to heart size or blood pressure.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976620-7

7 January 2021

The chyrnase A(-1903)G gene polymorphism is not associated with the risk and extent of coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976620-7

7 January 2021

Activation of cardiac aldosterone production in rat myocardial infarction: effect of angiotensin II receptor blockade and role in cardiac fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976620-7

7 January 2021

Associations between human aldosterone synthase (CYP11B2) gene polymorphisms and left ventricular size, mass, and function

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976620-7

7 January 2021

Analysis of promoter region polymorphism in the aldosterone synthase gene (CYP11B2) as a risk factor for myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976620-7

7 January 2021

Positional genomic analysis identifies the beta(2)-adrenergic receptor gene as a susceptibility locus for human hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976620-7

7 January 2021

Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976620-7

7 January 2021

Small LDL, atherogenic dyslipidemia, and the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976620-7

7 January 2021

Insulin resistance and hyperinsulinemia in individuals with small, dense low density lipoprotein particles

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976620-7

7 January 2021

A common mutation of the insulin receptor substrate-1 gene is a risk factor for coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976620-7

7 January 2021

Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976620-7

7 January 2021

[Diabetes mellitus, inflammation and coronary atherosclerosis: current and future perspectives]

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976620-7

7 January 2021

Hyperinsulinemia as an independent risk factor for ischemic heart disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976620-7

7 January 2021

[Current topics in vascular biology: an update for the 21st century]

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976620-7

7 January 2021

Polymorphism of the NADH/NADPH oxidase p22 phox gene in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976620-7

7 January 2021

NADH/NADPH oxidase p22 phox gene polymorphism is associated with improved coronary endothelial vasodilator function

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976620-7

7 January 2021

G894T polymorphism in the endothelial nitric oxide synthase gene is associated with an enhanced vascular responsiveness to phenylephrine

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976620-7

7 January 2021

A common variant of the endothelial nitric oxide synthase (Glu298-->Asp) is a major risk factor for coronary artery disease in the UK

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976620-7

7 January 2021

A missense Glu298Asp variant in the endothelial nitric oxide synthase gene is associated with coronary spasm in the Japanese

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976620-7

7 January 2021

A Quantitative Assessment of Plasma Homocysteine as a Risk Factor for Vascular Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976620-7

7 January 2021

Methylenetetrahydrofolate reductase genotypes and predisposition to atherothrombotic disease; evidence that all three MTHFR C677T genotypes confer different levels of risk

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976620-7

7 January 2021

Genetics of inflammation and risk of coronary artery disease: the central role of interleukin-6.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976620-7

7 January 2021

Effects of interleukin-1 gene polymorphisms on the development of coronary artery disease associated with Chlamydia pneumoniae infection

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976620-7

7 January 2021

Genetic variation at the chemokine receptors CCR5/CCR2 in myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976620-7

7 January 2021

C(-260)-->T polymorphism in the promoter of the CD14 monocyte receptor gene as a risk factor for myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976620-7

7 January 2021

Beta fibrinogen gene polymorphisms are associated with plasma fibrinogen and coronary artery disease in patients with myocardial infarction. The ECTIM Study. Etude Cas-Temoins sur l'Infarctus du Myocarde

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976620-7

7 January 2021

A common mutation (G-455--> A) in the beta-fibrinogen promoter is an independent predictor of plasma fibrinogen, but not of ischemic heart disease. A study of 9,127 individuals based on the Copenhagen City Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976620-7

7 January 2021

Bcl I polymorphism in the fibrinogen beta-chain gene is associated with the risk of familial myocardial infarction by increasing plasma fibrinogen levels. A case-control study in a sample of GISSI-2 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976620-7

7 January 2021

Polymorphisms in the Coagulation Factor VII Gene and the Risk of Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976620-7

7 January 2021

Polymorphisms in the factor VII gene and the risk of myocardial infarction in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976620-7

7 January 2021

Plasminogen-activator inhibitor type 1 and coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976620-7

7 January 2021

Tissue plasminogen activator and risk of myocardial infarction. The Rotterdam Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976620-7

7 January 2021

Platelet polymorphisms and ischemic heart disease: moving beyond traditional risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976620-7

7 January 2021

Increased Platelet Aggregability Associated With Platelet GPIIIa Pl A2 Polymorphism

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976620-7

7 January 2021

Meta-analysis of the association of platelet glycoprotein IIIa PlA1/A2 polymorphism with myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976620-7

7 January 2021

Role of Kozak sequence polymorphism of platelet glycoprotein Ibalpha as a risk factor for coronary artery disease and catheter interventions

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976620-7

7 January 2021

10.1016/S0300-8932(02)76620-7

Identifiers

DOI

1 reference

28 November 2017

1 reference

PubMed ID

11975906